CV NEWS FEED // Researchers’ recent systematic review of autopsies of people who received a COVID-19 vaccination “suggests there is a high likelihood of a causal link between COVID-19 vaccines and death.”
The review analyzed 325 autopsies and one organ-restricted autopsy of a heart and found that 240 deaths were “independently adjudicated as directly due to or significantly contributed to by COVID-19 vaccination.”
The review was published by Science, Public Health Policy and the Law, a journal that according to its website, “aims to publish objectively and ethically conducted studies and other scientific publications following rigorous peer review while eschewing ‘science’ enforced by official narratives.”
“Among adjudicators, there was complete independent agreement (all three physicians) of COVID-19 vaccination contributing to death in 203 cases (62.5%). The one organ-restricted autopsy case was judged to be linked to vaccination with complete agreement,” the review later added.
The analysis also revealed that the mean age of death was 70.4 years old and the most widely received vaccine was Pfizer/BioNTech (41%). Thirty-seven percent received the Sinovac vaccine, 13% AstraZeneca, 7% Moderna, 1% Johnson & Johnson, and 1% Sinopharm.
Of those who died following a COVID-19 vaccine, 49% died from heart complications, 17% from blood complications, and 11% from respiratory issues. Smaller numbers of people died as a result of other organ system complications, such as neurological or gastrointestinal issues.
According to the review, “Sudden cardiac death was the most common cause of death (21.2%),” while the average time between receiving a COVID-19 vaccine and death was found to be 14.3 days, irrespective of the dose.
The researchers called for “further urgent investigation” to confirm or deny their findings and ensure public health.
“Autopsies should be performed on all deceased individuals that have received one or more COVID-19 vaccines,” the researchers wrote in their review. “Clinical monitoring of COVID-19 vaccine recipients is indicated for a period of at least one year after vaccination to ensure the absence of serious adverse events that may lead to death.”
The full review is available here.